ENVALITH
ユキグニファクトリー株式会社 logo

YUKIGUNI FACTORY CO.,LTD.

1375Prime MarketFishery, Agriculture & Forestry

ユキグニファクトリー株式会社 logo
YUKIGUNI FACTORY CO.,LTD.1375

Mushroom Business

Core segment of Yukiguni Factory responsible for manufacturing and selling mushrooms (approx. 99% of consolidated revenue)

PeriodCurrentPreviousChange
Mushroom Business Revenue (Full Year)¥37,471 million¥36,779 million
Mushroom Business Segment Profit (Full Year)¥4,384 million¥2,511 million
Mushroom Business Depreciation and Amortization (Full Year)¥2,271 million¥2,324 million
Mushroom Business Impairment Loss (Full Year)¥98 million¥1,599 million
Maitake Revenue (Full Year)¥20,264 million¥20,055 million
Eryngii Revenue (Full Year)¥3,973 million¥3,822 million
Bunashimeji Revenue (Full Year)¥7,948 million¥7,563 million
Other Mushrooms Revenue (Full Year)¥5,284 million¥5,337 million

Business Details

The segment stably manufactures mushroom varieties—including maitake, eryngii, bunashimeji, mushroom, hon-shimeji, and hatake-shimeji—using industrial production methods, with sales centered on direct distribution to retailers. The company promotes a premium strategy centered on its proprietary "Kiwami" brand, supplying high-quality mushroom products to domestic and overseas customers. Overseas, group companies market exotic mushrooms in the European market. The segment applies IAS 41 "Agriculture," measuring biological assets at fair value.

Recent Overview

Segment profit rebounded sharply, up 74.6% year on year, mainly due to a significant reduction in impairment loss

Revenue in the mushroom business for FY2026 (ending March 2026) trended solidly at ¥37,471 million (up 1.9% year on year). Eryngii (+3.9%) and bunashimeji (+5.1%) led the growth, while maitake increased only 1.0% as an increase in sales volume offset a decline in average selling price. Segment profit rose sharply to ¥4,384 million (up 74.6% year on year), mainly due to the impairment loss shrinking to ¥98 million in the current period from ¥1,599 million in the prior period. In November 2025, the company upgraded its function to a Research and Development Division and newly established the Mushroom Research Institute and Mirai Research Institute.

Key Products

product
Maitake (Kiwami brand)

Product packaging was revamped in connection with the company name change. The company expanded convenient products with larger cluster cuts and newly designed products. FY2026 (ending March 2026) revenue was ¥20,264 million (up 1.0% year on year). The average selling price was below the prior period, but sales volume exceeded it. FY2027 (ending March 2027) revenue is projected at ¥20,660 million (up 2.0% year on year).

product
Eryngii

In addition to standard products, the company offers convenient cut eryngii products and weight-based sales products. In FY2026 (ending March 2026), both sales volume and average selling price exceeded the prior period, with revenue of ¥3,973 million (up 3.9% year on year). FY2027 (ending March 2027) revenue is projected at ¥4,260 million (up 7.1% year on year).

product
Bunashimeji

The company builds sales measures centered on single-cluster products while flexibly utilizing double-cluster products in response to fresh produce market conditions and market trends. In FY2026 (ending March 2026), both sales volume and average selling price exceeded the prior period, with revenue of ¥7,948 million (up 5.1% year on year). FY2027 (ending March 2027) revenue is projected at ¥7,980 million (up 0.4% year on year).

product
Other Mushrooms (Mushroom, Hon-shimeji, Hatake-shimeji, Overseas Business)

Mushroom, hatake-shimeji, and hon-shimeji trended sluggishly year on year, while exotic mushrooms from overseas group companies performed well. FY2026 (ending March 2026) revenue was ¥5,284 million (down 1.0% year on year). FY2027 (ending March 2027) revenue is projected at ¥6,360 million (up 20.3% year on year).

product
Biological Assets (IAS 41 Application)

The company applies IAS 41 "Agriculture," measuring biological assets in the mushroom production process at fair value less costs to sell. In FY2026 (ending March 2026), gains from fair value changes included in revenue were ¥15,604 million (down 2.7% year on year), and gains from fair value changes included in cost of sales were ¥15,532 million (down 1.4% year on year).

Growth Drivers

  • Improved average selling prices and expanded shelf share through the premium brand strategy (the "Kiwami" series)
  • Increased revenue contribution from improvements in both sales volume and average selling price for eryngii and bunashimeji
  • Expansion of exotic mushroom sales in Europe by overseas group companies (trending favorably)
  • Creation of new technologies and products through the upgrade to a Research and Development Division and the establishment of the Mushroom Research Institute/Mirai Research Institute
  • Improved production efficiency and labor-saving investment through FA (factory automation) and automation promotion (rationalization of all processes through BPR)
  • Expanded sales of the new business product "Kinoko no Niku" (Mushroom Meat) series (sales launched in February 2025)
  • Acquisition of a new user base through continuous promotion utilizing social media and digital media

Risks

  • Cost pressure from persistently elevated raw material costs, labor costs, logistics costs, and packaging material costs (further increases in material costs and labor costs expected in FY2027 as well)
  • Downward pressure on maitake average selling prices due to continued consumer thrift and selective spending
  • Uncertainty in profit or loss arising from fair value changes in biological assets under IAS 41 application (affected by fluctuations in production volume, sales volume, selling prices, etc.)
  • Risk of impairment losses (declined from ¥1,599 million in the prior period to ¥98 million in the current period, but underlying risk persists given the large amount of fixed assets)
  • Shrinking trend in the domestic food market due to the declining birthrate, aging population, and population decline
  • Impact of exchange rate fluctuations on raw material procurement costs and overseas business profit or loss
  • Uncertainty in the external environment due to geopolitical risks such as escalating tensions in the Middle East and US trade policy developments
  • Difficulty securing labor due to a shrinking domestic labor population and rising personnel costs

Last updated: June 25, 2026